@article{e5eac70bd85448b7a4a3bc9c13ee8c8e,
title = "Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia",
keywords = "Intensive chemotherapy, Personalized therapy, Patient samples, Azacitidine, Resistance, 3122 Cancers",
author = "Heikki Kuusanmaki and Sari Kyt{\"o}l{\"a} and Ida V{\"a}nttinen and Tanja Ruokoranta and Amanda Ranta and Jani Huuhtanen and Minna Suvela and Alun Parsons and Annasofia Holopainen and Anu Partanen and Kuusisto, \{Milla E. L.\} and Sirpa Koskela and Riikka R{\"a}ty and Maija It{\"a}l{\"a}-Remes and Imre V{\"a}strik and Olli Dufva and Sanna Siitonen and Kimmo Porkka and Krister Wennerberg and Heckman, \{Caroline A.\} and Pia Ettala and Marja Py{\"o}r{\"a}l{\"a} and Johanna Rimpil{\"a}inen and Timo Siitonen and Mika Kontro",
year = "2023",
month = jul,
doi = "10.3324/haematol.2022.281692",
language = "English",
volume = "108",
pages = "1768--1781",
journal = "Haematologica",
issn = "0390-6078",
publisher = "FERRATA STORTI FOUNDATION",
number = "7",
}